- Puma Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results
- Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
- Puma Biotechnology to Participate in a Panel Discussion at TD Cowen’s 44th Annual Health Care Conference
- Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results
- Puma Biotechnology Announces Initiation of ALISCA-Lung1 Phase II Trial of Alisertib in Small Cell Lung Cancer
- Puma Biotechnology to Present at B. Riley Securities 4th Annual Oncology Conference
More ▼
Key statistics
On Monday, Puma Biotechnology Inc (PBYI:NSQ) closed at 4.66, 118.78% above the 52 week low of 2.13 set on Oct 25, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.93 |
---|---|
High | 5.00 |
Low | 4.48 |
Bid | 3.30 |
Offer | 4.20 |
Previous close | 4.66 |
Average volume | 613.31k |
---|---|
Shares outstanding | 48.21m |
Free float | 40.57m |
P/E (TTM) | 10.32 |
Market cap | 224.65m USD |
EPS (TTM) | 0.4515 USD |
Data delayed at least 15 minutes, as of Mar 18 2024 20:00 BST.
More ▼